| Product Code: ETC11896786 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Erectile Dysfunction Drugs Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Erectile Dysfunction Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Erectile Dysfunction Drugs Market - Industry Life Cycle |
3.4 Japan Erectile Dysfunction Drugs Market - Porter's Five Forces |
3.5 Japan Erectile Dysfunction Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Japan Erectile Dysfunction Drugs Market Revenues & Volume Share, By Administration Route, 2021 & 2031F |
3.7 Japan Erectile Dysfunction Drugs Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Japan Erectile Dysfunction Drugs Market Revenues & Volume Share, By Mode of Action, 2021 & 2031F |
3.9 Japan Erectile Dysfunction Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Japan Erectile Dysfunction Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of erectile dysfunction in Japan due to lifestyle changes, stress, and underlying health conditions. |
4.2.2 Growing awareness and acceptance of erectile dysfunction as a medical condition leading to increased diagnosis and treatment-seeking behavior. |
4.2.3 Technological advancements in drug formulations and treatment options for erectile dysfunction. |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new erectile dysfunction drugs in Japan. |
4.3.2 Cultural taboos and stigma associated with discussing sexual health issues leading to underreporting and underdiagnosis of erectile dysfunction. |
5 Japan Erectile Dysfunction Drugs Market Trends |
6 Japan Erectile Dysfunction Drugs Market, By Types |
6.1 Japan Erectile Dysfunction Drugs Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Erectile Dysfunction Drugs Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Japan Erectile Dysfunction Drugs Market Revenues & Volume, By Phosphodiesterase Type 5 (PDE5) Inhibitors, 2021 - 2031F |
6.1.4 Japan Erectile Dysfunction Drugs Market Revenues & Volume, By Alprostadil, 2021 - 2031F |
6.1.5 Japan Erectile Dysfunction Drugs Market Revenues & Volume, By Testosterone Replacement Therapy, 2021 - 2031F |
6.1.6 Japan Erectile Dysfunction Drugs Market Revenues & Volume, By Herbal and Natural Supplements, 2021 - 2031F |
6.2 Japan Erectile Dysfunction Drugs Market, By Administration Route |
6.2.1 Overview and Analysis |
6.2.2 Japan Erectile Dysfunction Drugs Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Japan Erectile Dysfunction Drugs Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.2.4 Japan Erectile Dysfunction Drugs Market Revenues & Volume, By Topical, 2021 - 2031F |
6.2.5 Japan Erectile Dysfunction Drugs Market Revenues & Volume, By Sublingual, 2021 - 2031F |
6.3 Japan Erectile Dysfunction Drugs Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Japan Erectile Dysfunction Drugs Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Japan Erectile Dysfunction Drugs Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Japan Erectile Dysfunction Drugs Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.3.5 Japan Erectile Dysfunction Drugs Market Revenues & Volume, By Home Care, 2021 - 2031F |
6.4 Japan Erectile Dysfunction Drugs Market, By Mode of Action |
6.4.1 Overview and Analysis |
6.4.2 Japan Erectile Dysfunction Drugs Market Revenues & Volume, By Vasodilation, 2021 - 2031F |
6.4.3 Japan Erectile Dysfunction Drugs Market Revenues & Volume, By Hormonal Regulation, 2021 - 2031F |
6.4.4 Japan Erectile Dysfunction Drugs Market Revenues & Volume, By Nerve Stimulation, 2021 - 2031F |
6.4.5 Japan Erectile Dysfunction Drugs Market Revenues & Volume, By Muscle Relaxation, 2021 - 2031F |
6.5 Japan Erectile Dysfunction Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Japan Erectile Dysfunction Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.5.3 Japan Erectile Dysfunction Drugs Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5.4 Japan Erectile Dysfunction Drugs Market Revenues & Volume, By Online Sales, 2021 - 2031F |
6.5.5 Japan Erectile Dysfunction Drugs Market Revenues & Volume, By Direct Sales, 2021 - 2031F |
7 Japan Erectile Dysfunction Drugs Market Import-Export Trade Statistics |
7.1 Japan Erectile Dysfunction Drugs Market Export to Major Countries |
7.2 Japan Erectile Dysfunction Drugs Market Imports from Major Countries |
8 Japan Erectile Dysfunction Drugs Market Key Performance Indicators |
8.1 Average time from diagnosis to treatment initiation for erectile dysfunction patients in Japan. |
8.2 Number of healthcare providers trained in diagnosing and treating erectile dysfunction. |
8.3 Patient satisfaction and adherence rates with erectile dysfunction treatment regimens. |
9 Japan Erectile Dysfunction Drugs Market - Opportunity Assessment |
9.1 Japan Erectile Dysfunction Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Japan Erectile Dysfunction Drugs Market Opportunity Assessment, By Administration Route, 2021 & 2031F |
9.3 Japan Erectile Dysfunction Drugs Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Japan Erectile Dysfunction Drugs Market Opportunity Assessment, By Mode of Action, 2021 & 2031F |
9.5 Japan Erectile Dysfunction Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Japan Erectile Dysfunction Drugs Market - Competitive Landscape |
10.1 Japan Erectile Dysfunction Drugs Market Revenue Share, By Companies, 2024 |
10.2 Japan Erectile Dysfunction Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here